Doctor Shakhnoza Mukhtarova
Tashkent Pediatric Medical Institute, Tashkent (Uzbekistan)
Analysis of the use of incretins in patients with coronary artery disease with DM 2 with preserved ejection fraction.
Event: Heart Failure 2024
Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)
Session: ePosters in chronic heart failure - pathophysiology and mechanisms 5
Risk stratification of adverse events in patients with coronary artery disease with type 2 diabetes with preserved ejection fraction
Event: Heart Failure 2024
Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)
Session: ePosters in chronic heart failure - pathophysiology and mechanisms 5
